Glutathione S-transferase gene polymorphisms in multiple myeloma

J. Várkonyi, Lívia Jánoskúti, Dóra Szakály, Barbara Újvári, P. Pánczél, N. Hosszúfalusi, Peter Farkas, G. Mikala, A. Tordai, B. Schoket, I. Karádi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Background: Genetic variations exist in the genes coding for the gluthatione S-transferases (GSTs) that may contribute to the variations in the metabolic breakdown of environmental carcinogenic and chemotherapeutic agents. Such metabolic variations are also considered to contribute to differences in interindividual susceptibility to cancer and disease outcome. Materials and Methods: In this study the GSTM1, GSTT1 and GSTP1 Ile105Val gene polymorphisms have been determined in a study population of one hundred Hungarian myeloma patients and their hospitalized controls. Results: There was no significant difference in the genotype frequencies between cases and controls, with a notable exception, that in the group of patients with GSTT1 homozygous deletion (null) genotype, no GSTP1 105Val/105Val homozygous variant genotype was detected. For the combined GSTT1/GSTM1 genotypes, the shortest mean survival was observed in the GSTT1 null /GSTM1 null genotype group of patients. The GSTP1 Val/Val homozygous variant genotype also appeared to be a risk factor for shortest survival time, however, these trends were not statistically significant. Conclusions: GST gene polymorphisms may have only a weak, if any, effect in the outcome of multiple myeloma, which could be confirmed by large-scale international molecular epidemiological studies.

Original languageEnglish
Title of host publicationGlutathione: Biochemistry, Mechanisms of Action and Biotechnological Implications
PublisherNova Science Publishers, Inc.
Pages223-229
Number of pages7
ISBN (Print)9781624174605
Publication statusPublished - Feb 2013

Fingerprint

Glutathione Transferase
Polymorphism
Multiple Myeloma
Genes
Genotype
Transferases
Survival
Epidemiologic Studies
Population
Neoplasms

Keywords

  • GSTs
  • Impact on survival
  • Multiple myeloma
  • Predisposition to cancer

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Várkonyi, J., Jánoskúti, L., Szakály, D., Újvári, B., Pánczél, P., Hosszúfalusi, N., ... Karádi, I. (2013). Glutathione S-transferase gene polymorphisms in multiple myeloma. In Glutathione: Biochemistry, Mechanisms of Action and Biotechnological Implications (pp. 223-229). Nova Science Publishers, Inc..

Glutathione S-transferase gene polymorphisms in multiple myeloma. / Várkonyi, J.; Jánoskúti, Lívia; Szakály, Dóra; Újvári, Barbara; Pánczél, P.; Hosszúfalusi, N.; Farkas, Peter; Mikala, G.; Tordai, A.; Schoket, B.; Karádi, I.

Glutathione: Biochemistry, Mechanisms of Action and Biotechnological Implications. Nova Science Publishers, Inc., 2013. p. 223-229.

Research output: Chapter in Book/Report/Conference proceedingChapter

Várkonyi, J, Jánoskúti, L, Szakály, D, Újvári, B, Pánczél, P, Hosszúfalusi, N, Farkas, P, Mikala, G, Tordai, A, Schoket, B & Karádi, I 2013, Glutathione S-transferase gene polymorphisms in multiple myeloma. in Glutathione: Biochemistry, Mechanisms of Action and Biotechnological Implications. Nova Science Publishers, Inc., pp. 223-229.
Várkonyi J, Jánoskúti L, Szakály D, Újvári B, Pánczél P, Hosszúfalusi N et al. Glutathione S-transferase gene polymorphisms in multiple myeloma. In Glutathione: Biochemistry, Mechanisms of Action and Biotechnological Implications. Nova Science Publishers, Inc. 2013. p. 223-229
Várkonyi, J. ; Jánoskúti, Lívia ; Szakály, Dóra ; Újvári, Barbara ; Pánczél, P. ; Hosszúfalusi, N. ; Farkas, Peter ; Mikala, G. ; Tordai, A. ; Schoket, B. ; Karádi, I. / Glutathione S-transferase gene polymorphisms in multiple myeloma. Glutathione: Biochemistry, Mechanisms of Action and Biotechnological Implications. Nova Science Publishers, Inc., 2013. pp. 223-229
@inbook{90c41163013d43d5a1dfe7b5b789d114,
title = "Glutathione S-transferase gene polymorphisms in multiple myeloma",
abstract = "Background: Genetic variations exist in the genes coding for the gluthatione S-transferases (GSTs) that may contribute to the variations in the metabolic breakdown of environmental carcinogenic and chemotherapeutic agents. Such metabolic variations are also considered to contribute to differences in interindividual susceptibility to cancer and disease outcome. Materials and Methods: In this study the GSTM1, GSTT1 and GSTP1 Ile105Val gene polymorphisms have been determined in a study population of one hundred Hungarian myeloma patients and their hospitalized controls. Results: There was no significant difference in the genotype frequencies between cases and controls, with a notable exception, that in the group of patients with GSTT1 homozygous deletion (null) genotype, no GSTP1 105Val/105Val homozygous variant genotype was detected. For the combined GSTT1/GSTM1 genotypes, the shortest mean survival was observed in the GSTT1 null /GSTM1 null genotype group of patients. The GSTP1 Val/Val homozygous variant genotype also appeared to be a risk factor for shortest survival time, however, these trends were not statistically significant. Conclusions: GST gene polymorphisms may have only a weak, if any, effect in the outcome of multiple myeloma, which could be confirmed by large-scale international molecular epidemiological studies.",
keywords = "GSTs, Impact on survival, Multiple myeloma, Predisposition to cancer",
author = "J. V{\'a}rkonyi and L{\'i}via J{\'a}nosk{\'u}ti and D{\'o}ra Szak{\'a}ly and Barbara {\'U}jv{\'a}ri and P. P{\'a}ncz{\'e}l and N. Hossz{\'u}falusi and Peter Farkas and G. Mikala and A. Tordai and B. Schoket and I. Kar{\'a}di",
year = "2013",
month = "2",
language = "English",
isbn = "9781624174605",
pages = "223--229",
booktitle = "Glutathione: Biochemistry, Mechanisms of Action and Biotechnological Implications",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Glutathione S-transferase gene polymorphisms in multiple myeloma

AU - Várkonyi, J.

AU - Jánoskúti, Lívia

AU - Szakály, Dóra

AU - Újvári, Barbara

AU - Pánczél, P.

AU - Hosszúfalusi, N.

AU - Farkas, Peter

AU - Mikala, G.

AU - Tordai, A.

AU - Schoket, B.

AU - Karádi, I.

PY - 2013/2

Y1 - 2013/2

N2 - Background: Genetic variations exist in the genes coding for the gluthatione S-transferases (GSTs) that may contribute to the variations in the metabolic breakdown of environmental carcinogenic and chemotherapeutic agents. Such metabolic variations are also considered to contribute to differences in interindividual susceptibility to cancer and disease outcome. Materials and Methods: In this study the GSTM1, GSTT1 and GSTP1 Ile105Val gene polymorphisms have been determined in a study population of one hundred Hungarian myeloma patients and their hospitalized controls. Results: There was no significant difference in the genotype frequencies between cases and controls, with a notable exception, that in the group of patients with GSTT1 homozygous deletion (null) genotype, no GSTP1 105Val/105Val homozygous variant genotype was detected. For the combined GSTT1/GSTM1 genotypes, the shortest mean survival was observed in the GSTT1 null /GSTM1 null genotype group of patients. The GSTP1 Val/Val homozygous variant genotype also appeared to be a risk factor for shortest survival time, however, these trends were not statistically significant. Conclusions: GST gene polymorphisms may have only a weak, if any, effect in the outcome of multiple myeloma, which could be confirmed by large-scale international molecular epidemiological studies.

AB - Background: Genetic variations exist in the genes coding for the gluthatione S-transferases (GSTs) that may contribute to the variations in the metabolic breakdown of environmental carcinogenic and chemotherapeutic agents. Such metabolic variations are also considered to contribute to differences in interindividual susceptibility to cancer and disease outcome. Materials and Methods: In this study the GSTM1, GSTT1 and GSTP1 Ile105Val gene polymorphisms have been determined in a study population of one hundred Hungarian myeloma patients and their hospitalized controls. Results: There was no significant difference in the genotype frequencies between cases and controls, with a notable exception, that in the group of patients with GSTT1 homozygous deletion (null) genotype, no GSTP1 105Val/105Val homozygous variant genotype was detected. For the combined GSTT1/GSTM1 genotypes, the shortest mean survival was observed in the GSTT1 null /GSTM1 null genotype group of patients. The GSTP1 Val/Val homozygous variant genotype also appeared to be a risk factor for shortest survival time, however, these trends were not statistically significant. Conclusions: GST gene polymorphisms may have only a weak, if any, effect in the outcome of multiple myeloma, which could be confirmed by large-scale international molecular epidemiological studies.

KW - GSTs

KW - Impact on survival

KW - Multiple myeloma

KW - Predisposition to cancer

UR - http://www.scopus.com/inward/record.url?scp=84895352847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895352847&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84895352847

SN - 9781624174605

SP - 223

EP - 229

BT - Glutathione: Biochemistry, Mechanisms of Action and Biotechnological Implications

PB - Nova Science Publishers, Inc.

ER -